MACQUARIE GROUP LTD - VIKING THERAPEUTICS INC ownership

VIKING THERAPEUTICS INC's ticker is VKTX and the CUSIP is 92686J106. A total of 168 filers reported holding VIKING THERAPEUTICS INC in Q1 2019. The put-call ratio across all filers is 0.56 and the average weighting 0.2%.

Quarter-by-quarter ownership
MACQUARIE GROUP LTD ownership history of VIKING THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$3,654,000
-31.7%
330,1000.0%0.01%
-16.7%
Q2 2023$5,351,000
-2.6%
330,1000.0%0.01%
-14.3%
Q1 2023$5,496,000
+77.1%
330,1000.0%0.01%
+75.0%
Q4 2022$3,103,000
+245.5%
330,1000.0%0.00%
+300.0%
Q3 2022$898,000
-5.9%
330,1000.0%0.00%0.0%
Q2 2022$954,000
-4.2%
330,100
-0.6%
0.00%0.0%
Q1 2022$996,000
-34.8%
332,0480.0%0.00%0.0%
Q4 2021$1,527,000
-26.8%
332,0480.0%0.00%
-50.0%
Q3 2021$2,085,000
+4.8%
332,0480.0%0.00%0.0%
Q2 2021$1,989,000
-5.3%
332,0480.0%0.00%
-33.3%
Q1 2021$2,100,000
+12.2%
332,048
-0.2%
0.00%0.0%
Q4 2020$1,872,000
-3.3%
332,6450.0%0.00%0.0%
Q3 2020$1,936,000
-19.3%
332,6450.0%0.00%
-25.0%
Q2 2020$2,398,000
+55.2%
332,645
+0.8%
0.00%
+33.3%
Q1 2020$1,545,000
-41.6%
330,1000.0%0.00%
-25.0%
Q4 2019$2,647,000
+16.6%
330,1000.0%0.00%0.0%
Q3 2019$2,271,000
-72.4%
330,100
-66.7%
0.00%
-20.0%
Q2 2019$8,220,000
+105.6%
990,300
+146.2%
0.01%
-28.6%
Q1 2019$3,999,000
+19.4%
402,306
-8.1%
0.01%
+16.7%
Q4 2018$3,350,000
-49.0%
437,900
+16.2%
0.01%
-45.5%
Q3 2018$6,564,000
+109.5%
376,800
+14.1%
0.01%
+120.0%
Q2 2018$3,133,000
+34711.1%
330,100
+15619.0%
0.01%
Q4 2017$9,0002,1000.00%
Other shareholders
VIKING THERAPEUTICS INC shareholders Q1 2019
NameSharesValueWeighting ↓
DAFNA Capital Management LLC 450,900$2,624,0000.85%
Sio Capital Management, LLC 709,780$4,131,0000.82%
KNOTT DAVID M 218,102$1,269,0000.74%
ArrowMark Colorado Holdings LLC 7,988,635$46,494,0000.44%
Park West Asset Management LLC 1,457,507$8,483,0000.33%
VIRTUS ALTERNATIVE INVESTMENT ADVISERS, INC. 1,657$10,0000.18%
Virtus ETF Advisers LLC 42,507$247,0000.13%
Cornerstone Capital, Inc. 125,465$730,0000.10%
L & S Advisors Inc 114,988$669,0000.09%
EXANE DERIVATIVES 44,877$261,170,0000.08%
View complete list of VIKING THERAPEUTICS INC shareholders